The neurotrophic hypothesis proposes that a decrease in BDNF is implicated in the pathophysiology of depression, while an increase in BDNF is essential for the therapeutic effect of antidepressants (Yohn et al., 2017). This evidence concerns the gene BDNF and depressive symptom measurement.